Search PubMed⌕ Search

Biomedical subjects

S Chung

Publications and source records attributed to S Chung.

209 records · Page 12Linked to original sources
PubMed1977

Characterization of the integration protein of bacteriophage lambda as a site-specific DNA-binding protein.

The Int protein specified by bacteriophage lambda is required for the recombination event that integrates the viral DNA into the host genome at its specific attachment site. Using a DNA-binding assay, we have partially purified the Int protein and studied some of the features of its binding specificity and regulation. The DNA-binding activity is attributed to Int protein because the activity is eliminated by a nonsense mutation or a deletion in the int gene, and is rendered thermolabile by temperature-sensitive mutations in the int gene. The DNA-binding activity is specific for DNA carrying an appropriate attachment site, suggesting that Int protein directs the sequence-specific recognition essential for integrative recombination. The specific DNA-binding activity is also missing after infection by phage carrying mutations in the cII and cIII regulatory genes of lambda. This finding corroborates the conclusion from other types of experiments that regulation of the int and cI genes by cII/cIII provides for coordinate regulation of both major events of the lysogenic response, establishment of repression and insertion of viral DNA.

Carrier Proteins↗
PubMedDate not supplied

Effects of anti-epileptic drug therapy on bone mineral density in ambulatory epileptic children.

In order to assess the bone changes in the subjects receiving anti-epileptic drugs (AEDs), bone mineral densities (BMDs) of the arms, legs, ribs, pelvis, spine, and the whole body were scanned in 78 epileptic children and in 78 controls using dual photon absorptiometry. The study subjects were classified according to the duration of the monotherapy with phenobarbital (PB) or phenytoin (PHT); those who received AEDs for less than 12 months as Group I, for 13-23 months as Group II, and for 24 months as Group III. Group III was subclassified according to the kind of AEDs administered, into those receiving PB as Group IIIp, and those receiving PHT as Group IIId. There was no significant differences in the BMDs of each area, when compared to each control in Groups I and II. In Group III, there were significant differences in ribs and spine, according to the duration of administration. In Group IIIp, there was a significant difference in ribs and spine, and, in Group IIId, there was a significant difference in most of the areas. These results show that the measurement of BMDs in the ribs and spine is necessary for the early detection of subtle bone loss, and it is recommended that vitamin D be administered to children with epilepsy receiving AEDs over 24 months.

Absorptiometry, Photon↗
PubMedDate not supplied

Tumor necrosis factor-alpha-based gene therapy enhances radiation cytotoxicity in human prostate cancer.

The purpose of the present study was to determine the therapeutic potential of combining radiotherapy with tumor necrosis factor (TNF)-alpha-based gene therapy in the human prostate cancer PC-3 xenograft. PC-3 cells are highly resistant to TNF-alpha-induced cytotoxicity in vitro. A modest enhancement of radiation killing was observed with the addition of TNF-alpha in clonogenic survival assays. Combined treatment with Ad.Egr-TNF, a replication-deficient adenovirus modified to express TNF-alpha following the exposure of infected cells to ionizing radiation (40 Gy administered at 5 Gy per fraction) in vivo, resulted in increased tumor control, as defined by a reduction of tumor volume, when compared with treatment with Ad.Egr-TNF alone or with radiation alone (P < .03). The improvement in tumor control was achieved without increasing acute normal tissue damage when compared with tissue injury from radiation alone. The results of these studies support further development and clinical application of genetic radiotherapy for human prostate cancer.

Adenoviridae↗